Home › Funds › Balyasny Asset Management › CMPX
Balyasny Asset Management position in CMPX
COMPASS THERAPEUTICS INC · Health Care
Latest position (Q1 2026)1.12M sh
Reported value held$5.92M
Portfolio Weight0.01%
First reportedQ4 2022
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2022 | 28.79K | $144.83K | New |
| Q1 2023 | 26.83K | $87.73K | Reduce |
| Q1 2025 | 332.10K | $630.99K | New |
| Q3 2025 | 2.83M | $9.89M | New |
| Q4 2025 | 1.59M | $8.56M | Reduce |
| Q1 2026 | 1.12M | $5.92M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding CMPX
- Vanguard Group 8.05M sh · $43.22M · Q4 2025
- BlackRock Inc 11.28M sh · $24.71M · Q2 2026
- Millennium Management 4.71M sh · $10.32M · Q2 2026
- Geode Capital Management 3.82M sh · $8.36M · Q2 2026
- Citadel Advisors 3.71M sh · $8.12M · Q2 2026
- Goldman Sachs Group 3.53M sh · $7.73M · Q2 2026
- AQR Capital Management 3.51M sh · $7.69M · Q2 2026
- Royce & Associates 1.34M sh · $2.93M · Q2 2026
- Fidelity Management & Research (FMR) 1.21M sh · $2.65M · Q2 2026
- Northern Trust Corp 1.14M sh · $2.50M · Q2 2026
- JPMorgan Chase & Co 789.40K sh · $1.71M · Q2 2026
- Morgan Stanley 735.19K sh · $1.61M · Q2 2026